AKAN· Health Care› Drug Manufacturers - Specialty & Generic

Akanda Corp.

Stage 4 · Declining · week 14

As of Oct 22, 2026, Akanda is in Stage 4, the downtrend phase, now in week 14 (since Jul 16, 2026). It closed at $1.15, 98.0% below its 52-week high and below its 200-day average, which is falling.

Akanda Corp., through its subsidiaries, operates as early-stage cannabis company in Mexico. More about the company

$1.15

+2.68% today

$3.0M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is AKAN early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 76w

S4 35w

S4 14w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S4 76w → S1 8w → S4 13w → S1 8w → S4 35w → S1 11w → S4 14w current

Total tracked: 165 weeks across 7 stage runs.

AKAN among Drug Manufacturers - Specialty & Generic79th of 84 by relative strength

All 84 →

Stocks in Drug Manufacturers - Specialty & Generic ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	CPIXCumberland Pharmaceuticals Inc.	Stage 2 · wk 23	98	+6.8%
2	ETONEton Pharmaceuticals, Inc.	Stage 2 · wk 30	97	−10.1%
3	ANIKAnika Therapeutics Inc.	Stage 2 · wk 15	96	+3.5%
4	IRWDIronwood Pharmaceuticals, Inc. Class A	Stage 3 · wk 3	96	−16.4%
5	TEVATeva Pharmaceutical Industries Limited	Stage 2 · wk 9	95	+3.1%
6	AMRXAmneal Pharmaceuticals, Inc. Class A	Stage 2 · wk 19	95	+5.9%
7	KNSAKiniksa Pharmaceuticals International, plc Class A	Stage 2 · wk 73	95	+6.2%
8	AMLXAmylyx Pharmaceuticals, Inc.	Stage 2 · wk 15	93	−6.6%
…79	AKANAkanda Corp.	Stage 4 · wk 14	4	−63.0%

vs 52W High

-98.0%

$1.08 lo$57.09 hi

98.0% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 14

1w13w26w

Week 14, established downtrend

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-86.7%

200 DMA: $8.66 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

1.77x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-63.0%

-85.1%

-87.7%

YTD

-89.6%

-97.7%

Scan Membership

Not in any current scan.

Recent Stage Timeline

2026-10-22S4

Wk 14 · Vol 1.77x

2026-10-21S4

Wk 14 · Vol 1.38x

2026-10-20S4

Wk 14 · Vol 0.03x

2026-10-19S4

Wk 14 · Vol 0.12x

2026-10-16S4

Wk 14 · Vol 0.09x

2026-10-15S4

Wk 13 · Vol 0.06x

2026-10-14S4

Wk 13 · Vol 0.06x

2026-10-13S4

Wk 13 · Vol 0.08x

2026-10-12S4

Wk 13 · Vol 0.07x

2026-10-09S4

Wk 13 · Vol 0.04x

2026-10-08S4

Wk 12 · Vol 0.06x

2026-10-07S4

Wk 12 · Vol 0.05x

Moving averages & range

50 DMA

$2.97

200 DMA

$8.66

52W High

$57.09

52W Low

$1.08

5D Low

$1.08

Resistance levels (recent highs)

20d High

$3.05

60d High

$6.45

120d High

$41.08

250d High

$57.09

Next resistance

+165.2%

to 20d High

Dividend Yield

0.00%

P/B -0.1

Akanda: quick answers

What stage is Akanda in?

As of Oct 22, 2026, Akanda (AKAN) is in Stage 4, the downtrend phase. It entered Stage 4 on Jul 16, 2026 and is in week 14. What the four stages mean

Is Akanda in an uptrend?

No. Akanda is in a Stage 4 downtrend. It trades 86.7% below its 200-day average, which is falling.

How far is Akanda from its 52-week high?

Akanda closed at $1.15 on Oct 22, 2026, 98.0% below its 52-week high of $57.09. Its 52-week low is $1.08.

How has Akanda performed over the past year?

As of Oct 22, 2026, Akanda is down 97.7% over the past year and down 89.6% so far in 2026.

Which sector and industry is Akanda in?

Akanda is in the Drug Manufacturers - Specialty & Generic industry, part of the Health Care sector.

About this companyHealth Care· Drug Manufacturers - Specialty & Generic

Akanda Corp., through its subsidiaries, operates as early-stage cannabis company in Mexico. It is involved in medical cannabis cultivation, manufacturing, and sale; and leasing and/or rental of fiber optic networks and telecommunication towers. The company is based in Toronto, Canada.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.